1 / 39

SCREENING FOR EARLY BREAST CANCER IN DEVELOPING COUNTRIES

SCREENING FOR EARLY BREAST CANCER IN DEVELOPING COUNTRIES. The Cairo Breast Cancer Screening Trial. A PILOT STUDY OF 5000 WOMEN IN CAIRO. Dr. Salwa Boulos (Italian Hospital – Cairo – Egypt). In Egypt, breast cancer is the most common cancer in women.

consuelo
Télécharger la présentation

SCREENING FOR EARLY BREAST CANCER IN DEVELOPING COUNTRIES

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SCREENING FOR EARLY BREAST CANCER IN DEVELOPING COUNTRIES Annual Meeting 2005

  2. The Cairo Breast Cancer Screening Trial A PILOT STUDY OF 5000 WOMEN IN CAIRO • Dr. Salwa Boulos (Italian Hospital – Cairo – Egypt)

  3. In Egypt, breast cancer is the most common cancer in women. • The disease is usually diagnosed at an advanced stage, and survival is poor.

  4. AIM OF STUDY (CBST) • To test the feasibility of conducting a Breast Cancer Screening Program in a well defined, socio-economically modest population in the city of Cairo. • To pilot a Randomized Trial of Breast Physical Examination (CBE) and Breast Self-Examination (BSE)

  5. MATERIAL & METHODS • SAMPLE SIZE: 5000 women ( 35 - 65 years) • DURATION OF THE STUDY:Started 07/05/00 ended 28/11/02 • PHASES OF THE SUDY: The study was conducted in 2 phases: • Phase I • Phase II • Group A • Group B

  6. METHODOLOGY: 1. Geographical definition An area around the Italian Hospital, named Abbasiah District, was defined. The maps of this area were obtained and divided into 8 blocks.

  7. *METHODOLOGY (Cont.):2. Door-to-Door visits4 Social workers were selected and trained about the objectives and methodology of the study.

  8. 2. Door-to-Door visits (Cont.)Questionnaire

  9. 3. Women invited to attend a Health Education Session in a primary health care center (PHC)

  10. (a) Brief health talk by doctors.

  11. ( b ) Clinical Breast Examination (in a private room) ( c ) Teaching of Breast Self Examination

  12. 4- Referral to the Italian Hospital of any woman with suspicious finding for:a) CBE by Chief Surgeon. (Confirm)

  13. b) Further investigation (+/- MX and U.S.)

  14. c) Further surgical treatment (free of cost).

  15. Phase II : Women who had previously been contacted were randomly classified into two groups (using area / block randomization) . Group A : To be invited to attend once more the PHC for examination Group B : To be visited only and asked about breast Problems

  16. RESULTS

  17. Results of phase IField Study Rates • No. of women contacted  4116 out of 5000 • . Community Acceptance Rate  4116/5000

  18. Field Study Rates (Cont.) • Compliance Rate at PRIMARY HEALTH CARE : 2481/ 4116

  19. Results of CBE at PHC • Total examined: 2481 • Number found abnormal and referred to Italian Hospital for further evaluation: 291 (11.7%)

  20. Compliance Rate at ITALIAN HOSPITAL 55 out of 291 (18.9%) women with abnormalities detected at PHC did not show up at the hospital for further investigation 236/291

  21. Results Of Investigations

  22. variables that were significantly associated with breast cancer 1- Age (rate per 1000) Age Groups ( years )

  23. Variables that were significantly associated with breast cancer(Cont.) • 2- Family History. • 3- Gravida. • 4- Regularity of menstrual cycle. • 5- Occupation / Education.

  24. Variables that were not significantly associated with breast cancer • 1- Smoking. • 2- Breast Feeding. • 3- Birth Control Methods. • 4- History of Hormonal Treatment.

  25. Results of Phase II : GROUP A • Total No. of Women contacted 1924 Out of which • 1237 Attended PHC during Phase I • 687 did NOT attend

  26. Results of Phase II : GROUP ABreast Cancer Detection Rates (per 1000) • Attended PHC and normal: 0.8 • Attended PHC and referred with abnormal finding for Italian Hospital , but did not attend for diagnosis: 49.4 • Did not attend PHC in Phase I, but attended PHC in Phase II: 2.9

  27. Results of Phase II : GROUP B • Total No. of women contacted 1927 Out of which • 1062 had attended PHC Phase I • 865 did Not attend PHC

  28. Results of Phase II : GROUP B Interval cases of breast cancer following first screen: • Among women who attended PHC in phase I = 3 / 1062 2.8 per 1000 • Among women who did NOT attend = 3 / 865 3.5 per 1000

  29. Staging of Malignant Tumors (pathology stage) Staging Phase I Phase II (A) Phase II (B) n=16 n=7 n=5 Stage 0 1 (6.2%) 0 (0.0%) 0 (0.0%) Stage I 4 (25.0%) 2 (28.6%) 0 (0.0%) Stage II 9 (56.2%) 1 (14.3%) 2 (40.0%) Stage III 1 (6.2%) 3 (42.8%) 3 (60.0%) Stage IV 1 (6.2%) 1 (14.3%) 0 (0.0%) 4 cases diagnosed by FNAC 1 case not doc.

  30. In the year 2003/2004, the trial has been extended in Cairo by the identification, recruitment and randomization of a second group of 5000 women from a different district (( Area no.2 ))

  31. From the start, women were randomly allocated into 2 groups: Group A (2500) Study arm Group B (2500) Control arm Both areas of residency are quite far from each other.

  32. Results – Area 2 • Study Group A: *No. of women contacted 2264 out of 2500 *Community acceptance rate (90.6%) *Compliance rate at PHC 1861/2264 (82%) *Compliance rate at Italian Hospital 77/88 (87.5%) *Cancer Detection rate 10/1861 (5.4 per 1000)

  33. Results (Cont.) • Study Group B: * No. of women contacted 2176 out of 2500 * Community acceptance rate 87%

  34. Results (Cont.) *Symptomatic cancer diagnosed as a result of study activities: 1/2176 (0.5 per 1000)

  35. Staging of Malignant Tumors: Staging No. Of cases (%) Stage Group A Group B No=10 No=1 Stage 0 0 1 ( 7.7%) Stage I 3 (33.3%) Stage II 4 (33.4%) Stage III 3 (33.3%)Stage IV Stage IV 0

  36. May 2005, follow up (Area 2 ) Group A - Study arm • Total number of women accepted to participate in phase 1 = 2264 • Total No. of women at risk for cancer in phase 2 = 2254 • Compliance rate at PHC = 1852/2254 = 73% • Compliance rate at IH = 52/56 = 93% • Cancer Detection rate = 6 /1852 = 3.2 per 1000 women

  37. May 2005, follow up (Area 2 ) Group B- Control arm • Total number of women accepted to participate in phase 2 = 2215 • Community Acceptance Rate= 2215/2500 = 88.6% • Cancer Detection rate = 2 /2202 = 0.9 per 1000 women

  38. New Area with 5000 women(( Area No. 3 )) • April 2005, a third group of 5000 women from a different district were recruited and randomized as follows : • Group A (2500) Study arm • Group B (2500) Control arm

  39. Thank You

More Related